15 results
424B3
AMYT
Amryt Pharma Plc
1 Jul 21
Prospectus supplement
5:20pm
company.
Chiasma is a target of a lawsuit that could result in substantial costs and may delay or prevent the merger from being completed … and the key inputs for the financial analyses performed by Duff & Phelps. The lawsuit seeks various remedies,
including a preliminary and/or permanent
F-4/A
AMYT
Amryt Pharma Plc
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
interest after the merger and will exercise less influence over the management of the combined company.
Chiasma is a target of a lawsuit that could result … & Phelps. The lawsuit seeks various remedies,
including a preliminary and/or permanent injunction prohibiting consummation of the proposed
20-F
2020 FY
AMYT
Amryt Pharma Plc
30 Apr 21
Annual report (foreign)
12:53pm
infringement lawsuit against a biosimilar or interchangeable product sponsor. Unlike the Hatch-Waxman Act, the BPCI Act provides no automatic stay
424B4
zlf 3oe1bfcpb1xf
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
alyyhe3n6bjztwr9
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
p1gyne2dizsew5f3sl
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
qmg8d0key 1jkt6dex
18 Dec 20
Draft registration statement
12:00am
424B4
2iuwoidbsd yzex
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
uf80dul8
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.1
mjsgfzr 9b6fc7bw
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
zcttn0f40yi4
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
3hp5jf0
29 May 20
Draft registration statement (amended)
12:00am
DRS
tzg12wdzsb8u ta
19 Feb 20
Draft registration statement
12:00am
- Prev
- 1
- Next